News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024
·
8 min read
Press Releases
Optimi Health and Psyence Biomedical Sign Non-Binding Letter of Intent to Advance Global Psilocybin Drug Development
August 13, 2024
·
9 min read
Press Releases
Defence Therapeutics Collaboration Agreement with Orano to Develop the Next Generation of Targeted Radio-Immunotherapy for Cancer Advances
August 13, 2024
·
5 min read
Press Releases
Therma Bright Welcomes Medical & Pharmaceutical Veteran Michael Raimondo to Its Advisory Board
August 13, 2024
·
4 min read
Press Releases
Telo Genomics Receives CLIA Certification
August 13, 2024
·
4 min read
Press Releases
Marvel Announces Its Collaboration with FRAXA to Test MB204 In Pre-Clinical Models of Fragile X Syndrome
August 13, 2024
·
5 min read
Press Releases
FSD Pharma Announces Share Consolidation and Name Change
August 12, 2024
·
11 min read
Press Releases
Adaptimmune Reports Q2 2024 Financial and Business Updates
August 12, 2024
·
14 min read
Press Releases
Britannia Life Sciences Inc. Provides Update on Cease Trade Order
August 12, 2024
·
3 min read
Press Releases
Awakn Announces First Patient Screened in Phase 3 Clinical Trial of AWKN-001 for Severe Alcohol Use Disorder
August 9, 2024
·
9 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us